Inhaled Long-Acting Β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis
PLoS ONE - United States
doi 10.1371/journal.pone.0137904
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 17, 2015
Authors
Publisher
Public Library of Science (PLoS)